816
S. Gogoi et al. / Tetrahedron Letters 52 (2011) 813–816
2. (a) stby, O. B.; Dalhus, B.; Gundersen, L.-L.; Rise, F.; Bast, A.; Haenen, G. R. M. M.
16. (a) Takada, K.; Haginiwa, J.; Murakoshi, I. Chem. Pharm. Bull. 1976, 24, 2265; (b)
Tominaga, Y.; Gotou, H.; Oniyama, Y.; Nishimura, Y.; Matsuda, Y. Chem. Pharm.
Bull. 1985, 33, 3038.
17. Borthakur, M.; Gogoi, S.; Gogoi, J.; Boruah, R. C. Tetrahedron Lett. 2010, 51, 5160.
18. Typical procedure for the preparation of cycl[3.2.2]azine (4a): (a) Thermal
Eur. J. Org. Chem. 2000, 3763; (b) Medda, S.; Jaisankar, P.; Manna, R.; Pal, B.; Giri,
V. S.; Basu, M. K. J. Drug Target 2003, 11, 123; (c) Bolle, L. D.; Andrei, G.; Snoeck,
R.; Zhang, Y.; Lommel, A. V.; Otto, M.; Bousseau, A.; Roy, C.; Clercq, E. D.;
Naesens, L. Biochem. Pharmacol. 2004, 67, 325; (d) Wang, P.; Zhang, Z.; Ma, X.;
Huang, Y.; Liu, X.; Tu, P.; Tong, T. Mech. Ageing Dev. 2003, 124, 1025; (e)
Jrgensen, A. S.; Jacobsen, P.; Christiansen, L. B.; Bury, P. S.; Kanstrup, A.; Thorpe,
S. M.; Bain, S.; Naerum, L.; Wassermann, K. Bioorg. Med. Chem. Lett. 2000, 10,
399.
condition: To
a
mixture of 2-picoline (0.12 ml, 1 mmol),
a-
bromoacetophenone (240 mg, 1.2 mmol) and DMAD (0.18 ml, 1.5 mmol) in
water (10 ml) was added K2CO3 (207 mg, 1.5 mmol) and the mixture was
heated to 100 °C. The reaction was monitored by TLC and on completion of the
reaction after 1 h, the reaction mixture was cooled and extracted with CH2Cl2
(3 ꢀ 20 ml). The organic portion was washed with water, dried over anhydrous
Na2SO4 and the solvent was removed to obtain a crude product. Preparative
TLC separation using EtOAc/hexane (10:90) as eluant afforded 2-phenyl-4,5-
dicarbmethoxy-cycl[3.2.2]azine 4a in 70% yield. (b) Microwave condition: A
3. Chai, W.; Breitenbucher, J. W.; Kwok, A.; Li, X.; Wong, V.; Carruthers, N. I.;
Lovenberg, T. W.; Mazur, C.; Wilson, S. J.; Axe, F. U.; Jones, T. K. Bioorg. Med.
Chem. Lett. 2003, 13, 1767.
4. Gundersen, L.-L.; Negussie, A. H.; stby, O. B. Arch. Pharm. Pharm. Med. Chem.
2003, 336, 191.
5. (a) Hutchinson, J. H.; Therien, M.; Frenette, R. Eur. Pat. Appl. EP542355, 1993.;
(b) Zhu, L.; Vimolratana, M.; Boown, S. P.; Medina, J. C. Tetrahedron Lett. 2008,
49, 1768.
6. Gupta, S. P.; Mathur, A. N.; Nagappa, A. N.; Kumar, D.; Kumaran, S. Eur. J. Med.
Chem. 2003, 38, 867.
mixture of 2-picoline (0.12 ml, 1 mmol), a-bromoacetophenone (240 mg,
1.2 mmol), DMAD (0.18 ml, 1.5 mmol) and K2CO3 (207 mg, 1.5 mmol) was
taken in water (10 ml) and the mixture was irradiated in an open vessel of
Synthwave 402 Prolabo focused microwave reactor at 100 °C and power at 60%
(maximum output 300 W). The reaction was monitored by TLC and upon
completion of reaction after 2 min, the reaction mixture was cooled and
extracted with CH2Cl2 (3 ꢀ 20 ml). The organic portion was washed with
water, dried over anhydrous Na2SO4, and the solvent removed to obtain a
crude product. Preparative TLC separation using EtOAc/hexane (10:90) as
eluant afforded 4a in 90% yield.
7. (a) Gundersen, L.-L.; Malterud, K. E.; Negussie, A. H.; Rise, F. R.; Teklu, S.; stby,
O. B. Bioorg. Med. Chem. 2003, 11, 5409; (b) Teklu, S.; Gundersen, L.-L.; Larsen,
T.; Malterud, K. E.; Rise, F. Bioorg. Med. Chem. 2005, 13, 3127.
8. (a) Fang, X.; Wu, Y. M.; Deng, J.; Wang, S. W. Tetrahedron 2004, 60, 5487; (b)
Yan, B.; Liu, Y. Org. Lett. 2007, 9, 4323; (c) Bora, U.; Saikia, A.; Boruah, R. C. Org.
Lett. 2003, 5, 435; (d) Kim, I.; Choi, J.; Won, H. K.; Lee, G. H. Tetrahedron Lett.
2007, 48, 6863; Kaloko, J., Jr.; Hayford, A. Org. Lett. 2005, 7, 4305; (e) Liu, Y.;
Song, Z.; Yan, B. Org. Lett. 2007, 9, 409; (f) Smith, C. R.; Bunnelle, E. M.; Rhodes,
A. J.; Sarpong, R. Org. Lett. 2007, 9, 1169; (g) Seregin, I. V.; Gevorgyan, V. J. Am.
Chem. Soc. 2006, 128, 12050; (h) Kel’in, A. V.; Sromek, A. W.; Gevorgyan, V. J.
Am. Chem. Soc. 2001, 123, 2074.
9. (a) Tschitschbabin, A. E. Ber. Dtsch. Chem. Ges. 1927, 60, 1606; (b) Hurst, J.;
Melton, T.; Wibberley, D. G. J. Chem. Soc. 1965, 2948; (c) Jones, G.; Stanyer, J. J.
Chem. Soc. C 1969, 901; (d) Katritzky, A. R.; Qui, G.; Yang, B.; He, H.-Y. J. Org.
Chem. 1999, 64, 7618; (e) Kostix, E. I.; Abiko, A.; Oku, A. J. Org. Chem. 2001, 66,
2618.
10. (a) Klijin, J. E.; Engberts, J. B. F. N. Nature 2005, 435, 746; (b) Narayan, S.;
Muldoon, J.; Finn, M. G.; Fokin, V. V.; Kolb, H. C.; Sharpless, K. B. Angew.
Chem., Int. Ed. 2005, 44, 3275; (c) Grieco, P. A.; Parker, D. T.; Fobare, W. F.;
Ruckle, R. J. Am. Chem. Soc. 1987, 109, 5859; (d) Grieco, P. A.; Bahsas, A. J. Org.
Chem. 1987, 52, 5746; (e) Otto, S.; Blokzijl, W.; Engberts, J. B. F. N. J. Org.
Chem. 1994, 59, 5372; (f) Das, B.; Satyalakshmi, G.; Suneel, S.; Damodar, K. J.
Org. Chem. 2009, 74, 8400; (g) Arvela, R. K.; Leadbeater, N. E. Org. Lett. 2005, 7,
2101; (h) Fujihara, T.; Yoshida, S.; Terao, J.; Tsuji, Y. Org. Lett. 2009, 11,
2121.
11. (a) Varma, R. S. In Microwaves: Theory and Application in Material Processing IV;
Clark, D. E., Sutton, W. H., Lewis, D. A., Eds.; American Ceramic Society:
Westerville, OH, 1997; pp 357–365; (b) Varma, R. S.; Dahiya, R. Tetrahedron
1998, 54, 6293; (c) Varma, R. S.; Meshram, H. M. Tetrahedron Lett. 1997, 38,
7973.
2-Phenyl-4,5-dicarbmethoxy-cycl[3.2.2]azine 4a: yellow needles, mp 139–42 °C
(dec); Rf = 0.5 (EtOAc/Hexane = 10:90); IR (CHCl3) cmꢁ1
:
m
2924, 2853, 1716,
1705, 1617, 1487, 1256, 1209, 1169, 1117, 1067, 772; 1H NMR (CDCl3,
300 MHz): d 7.93–8.42 (4H, m), 7.43–7.52 (5H, m), 4.02 (3H, s), 3.96 (3H, s). 13
C
NMR (CDCl3, 75 MHz): d 166.7, 164.3, 137.4, 134.1, 132.3, 129.6, 129.1, 128.8,
128.5, 125.6, 125.1, 122.6, 119.8, 116.4, 114.3, 112.2, 111.6, 100.4, 52.9, 51.8; EI
mass m/z = 333 [M+]. 2-Phenyl-4-carbethoxy-cycl[3.2.2]azine 4e: yellow needles,
mp 112–15 °C (dec); Rf = 0.55 (EtOAc/Hexane = 10:90): IR (CHCl3) cmꢁ1
: m
2924, 1698, 1610, 1505, 1256, 1176, 1097, 772; 1HNMR (CDCl3, 300 MHz) d
8.37 (1H, d, J = 4.7 Hz), 8.33 (1H, s), 8.05 (1H, d, J = 4.7 Hz), 7.90 (1H, d,
J = 4.6 Hz), 7.85 (3H, m), 7.51 (1H, s), 7.54 (1H, t, J = 4.6 Hz), 7.41 (1H, t,
J = 4.5 Hz), 4.50 (2H, q, J = 4.3 Hz), 1.51 (3H, t, J = 4.3 Hz); 13CNMR CDCl3,
75 MHz): d 165.2, 135.7, 134.1, 132.0, 129.9 (2C), 129.1, 128.5, 127.6 (2C),
124.4, 119.6, 114.7 (2C), 114.5, 113.1, 109.1, 60.2, 14.6; EI mass m/z 289 [M+].
2-(30-Acetoxy-50,160-dieno-androst-17-yl)-4,5-carbmethoxy-cycl[3.2.2]azine
4j: light yellow crystal, mp 203–05 °C (dec); Rf = 0.50 (EtOAc/Hexane = 10:90):
IR (CHCl3) cmꢁ1 2930, 1710, 1702, 1613, 1510, 1260, 1090, 770; 1HNMR
: m
(CDCl3, 300 MHz) d 8.28 (1H, d, J = 4.8 Hz), 8.17(1H, m), 8.02 (1H, d, J = 4.8 Hz),
7.51 (1H, s), 6.50 (1H, br s), 5.62 (1H, br s), 4.70 (1H, m), 4.10 (3H, s), 4.01 (3H,
s), 2.35–1.20 (17H, m), 2.10 (3H, s), 1.20 (3H, s), 1.03 (3H, s); 13CNMR CDCl3,
75 MHz): d 165.8, 164.9, 163.6, 153.4, 139.2, 139.0, 138.5, 127.8, 126.3 (2C),
125.6, 124.8, 122.4 (2C), 118.2, 113.3, 104.4, 72.5, 58.9, 55.1, 49.2, 46.8, 37.1,
35.8, 33.2, 31.7, 30.5, 29.1, 28.7, 26.4, 19.4, 18.6, 15.4, 15.3, 15.2; EI mass m/z
569 [M+].
19. The regioselectivity of the products 4e–i were in compliance with the reported
frontier orbital treatment of 1,3-dipolar cycloaddition reactions: Houk, K. N.;
Sims, J.; Watts, C. R.; Luscos, L. J. J. Am. Chem. Soc. 1973, 95, 7301.
20. Preparation of Tschitschibabin 2-phenyl-indolizine (B): A mixture of 2-picoline
12. (a) Kabalka, G. W.; Wang, L.; Pagni, R. M. Synlett 2001, 676; (b) Ranu, B. C.;
Hajra, A.; Jana, U. Tetrahedron Lett. 2000, 41, 531; (c) Bose, A. K.; Manhas, M. S.;
Ganguly, S. N.; Sharma, A. H.; Banik, B. K. Synthesis 2002, 1578; (d) Bagley, M.
C.; Cale, J. W.; Baueer, J. Chem. Commun. 2002, 1682.
(0.12 ml, 0.1 mmol),
a-bromoacetophenone (240 ml, 1.2 mmol), and K2CO3
13. (a) Barthakur, M. G.; Borthakur, M.; Devi, P.; Saikia, C. J.; Saikia, A.; Bora, U.;
Chetia, A.; Boruah, R. C. Synlett 2007, 223; (b) Borthakur, M.; Boruah, R. C.
Steroids 2008, 73, 637.
14. (a) Flish, W.; Kramer, U. Adv. Heterocycl. Chem. 1978, 22, 582; (b) Abe, N.;
Nishiwaki, T.; Yamamoto, H. Chem. Lett. 1982, 805; (c) Boekelheide, V.; Small, T.
J. Am Chem. Soc. 1961, 83, 462.
15. (a) Uchida, T.; Matsumoto Chem. Lett. 1980, 149; (b) Tominaga, Y.;
Shiroshita, Y.; Kurokawa, T.; Gotou, H.; Matsuda, Y.; Hosomi, A. J. Heterocycl.
Chem. 1989, 26, 477; (c) Windgassen, R. J.; Saunders, W. H., Jr.; Boekelheide, V.
J. Am Chem. Soc. 1959, 81, 1459; (d) Galbraith, A.; Small, T.; Barner, R. A.;
Boekelheide, V. J. Am Chem. Soc. 1961, 83, 453; (e) Godfry, J. J. Org. Chem. 1959,
24, 581; (f) Galbraith, A.; Small, T.; Boekelheide, V. J. Org. Chem. 1959, 24,
582.
(207 mg, 1.5 mmol) was taken in water (10 ml) and irradiated in an open
vessel of Synthwave 402 Prolabo focused microwave reactor at 100 °C and
power at 60% (Maximum output 300 W). On completion of reaction after
1 min, the reaction mixture was cooled and extracted with CH2Cl2 (3 ꢀ 20 ml).
The organic portion was washed with water, dried over anhydrous Na2SO4, and
the solvent removed to obtain a crude product, which on purification afforded
B in 93% yield. mp 188–90 °C; Rf = 0.6 (EtOAc/Hexane = 05:95): IR (CHCl3)
cmꢁ1 2920, 1633, 1604, 1452, 1384, 1297, 1252, 781, 755; 1HNMR (CDCl3,
: m
300 MHz) d 7.88 (1H, d, J = 6.8 Hz), 7.65 (1H, d, J = 7.6 Hz), 7.56 (1H, s), 7.32
(3H, m), 7.25 (2H, J = 6.9 Hz), 6.69 (1H, s), 6.66 (1H, m), 6.44 (1H, m); 13CNMR
CDCl3, 75 MHz): d 135.0, 13.3, 129.1 (2C), 128.5, 226.2, 125.9, 125.6, 124.8,
118.7, 117.1, 110.2, 108.9, 96.3; ESI mass m/z 193 [M+].
21. Borthakur, M.; Barthakur, M. G.; Boruah, R. C. Steroids 2008, 73, 539.